Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

NCT03901963

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC - HAL Glendale, Arizona, United States
  • Cancer Treatment Center of America Phoenix Goodyear, Arizona, United States
  • University of California San Diego (UCSD) - The Rebecca and John Moores Cancer Center La Jolla, California, United States
View all 73 locations
View Trial Details
Completed

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03651128

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 109 Birmingham, Alabama, United States
  • Local Institution - 141 Scottsdale, Arizona, United States
  • Local Institution - 145 Los Angeles, California, United States
  • Local Institution - 122 Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

NCT01946477

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Local Institution - 126 Tucson, Arizona, United States
  • Local Institution - 137 Greenbrae, California, United States
  • Local Institution - 109 Los Angeles, California, United States
  • Local Institution - 104 Pleasant Hill, California, United States
View all 49 locations
View Trial Details
Completed

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

NCT02332850

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

NCT01702831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada
  • Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
View Trial Details

Related conditions